Invention Application
- Patent Title: PROTEIN KINASE INHIBITORS
-
Application No.: US13593674Application Date: 2012-08-24
-
Publication No.: US20120322793A1Publication Date: 2012-12-20
- Inventor: Jean-Damien Charrier , Steven Durrant
- Applicant: Jean-Damien Charrier , Steven Durrant
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K31/551
- IPC: A61K31/551 ; C07D487/16 ; A61P35/04 ; A61P25/28 ; C12N9/99 ; A61P19/00 ; A61P7/00 ; A61P35/02 ; A61P37/00 ; A61P31/12 ; C07D487/04 ; A61P1/16
Abstract:
In one aspect, the invention provides compounds of Formula I or pharmaceutically acceptable salts thereof. In another aspect, the invention provides methods for treatment of diseases or disorders mediated by a protein kinase, comprising administering a therapeutically effective amount of a compound of this invention.
Public/Granted literature
- US08618106B2 Protein kinase inhibitors Public/Granted day:2013-12-31
Information query
